Genomic analysis. (A) A schematic representation of the signaling mutations in the 17 patients and of the type of hematopoiesis in triple-negative ETs. We consider as polyclonal ETs the patients that exhibit no mutation (driver or passenger) in WES. (B) Sanger sequencing of MPLS204P. Nucleotides and amino acid numbers are indicated.